Showing 7541-7550 of 10620 results for "".
- GLP-1 Drugs: A Promising Therapeutic Approach for Kidney Transplant Recipients with Type 2 Diabeteshttps://reachmd.com/news/glp-1-drugs-a-promising-therapeutic-approach-for-kidney-transplant-recipients-with-type-2-diabetes/2471590/Recent investigations highlight emerging evidence that GLP-1 drugs, traditionally used for anti‐obesity and metabolic regulation, may also reduce organ failure rates and improve survival in kidney transplant recipients with type 2 diabetes. Expl
- Exploring Socioeconomic Determinants in Pediatric COVID-19 Vaccine Hesitancyhttps://reachmd.com/news/exploring-socioeconomic-determinants-in-pediatric-covid-19-vaccine-hesitancy/2471561/Recent observations in the San Francisco Bay Area indicate that low parental income levels are associated with increased vaccine hesitancy among the pediatric population, highlighting significant socioeconomic barriers to COVID-19 vaccination.
- Revolutionizing Cardiac Care: The Living Mitral Valve Transplant Breakthroughhttps://reachmd.com/news/revolutionizing-cardiac-care-the-living-mitral-valve-transplant-breakthrough/2471465/Duke Health has performed the world’s first living mitral valve transplant, a pioneering procedure in pediatric cardiac surgery. The operation, which involved transplanting healthy valves from a full-heart transplant recipient to two other children, cou
- Evaluating the Accuracy of Continuous Glucose Monitors: A Comparative Insighthttps://reachmd.com/news/evaluating-the-accuracy-of-continuous-glucose-monitors-a-comparative-insight/2471457/A Closer Look at CGM Accuracy: Balancing Innovation with Clinical Realities This article examines the differences between continuous glucose monitor readings and capillary blood glucose measurements, with a focus on fasting and post-meal levels. It brings into pers
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://reachmd.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical use with
- Revolutionizing Medical Imaging: AI's Role in Detecting Subtle Changes and Predicting Outcomeshttps://reachmd.com/news/revolutionizing-medical-imaging-ais-role-in-detecting-subtle-changes-and-predicting-outcomes/2471477/Recent advancements in artificial intelligence have paved the way for revolutionary breakthroughs in medical imaging. A collaborative effort by researchers at Weill Cornell Medicine, Cornell’s Ithaca campus, and Cornell Tech has led to the development of an AI system that c
- Innovative CT Scan Technique Transforms Prognosis for Head and Neck Cancershttps://reachmd.com/news/innovative-ct-scan-technique-transforms-prognosis-for-head-and-neck-cancers/2471475/Advanced Diagnostic Imaging Enhances Treatment Predictions in Younger Populations A new study highlights how advanced CT imaging techniques can assist oncologists in predicting treatment responses and improving survival rates, particularly for head and neck cancers
- Get In First: A Derm's Case for Early Psoriasis Treatmenthttps://reachmd.com/news/from-aad-2025-a-case-for-early-psoriasis-treatment/2471544/Addressing psoriasis early in its course may lead to prolonged remission and better outcomes, and dermatologists should take note, according to a presentation at the 2025 American Academy of Dermatology Annual Meeting in Orlando.
- 2025 AAD Meeting: The Power of Social Media in Dermatology to Educate, Engage, and Inspirehttps://reachmd.com/news/2025-aad-meeting-the-power-of-social-media-in-dermatology-to-educate-engage-and-inspire/2473749/Combatting misinformation that is spread on social media was one of the session topics at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida on Friday. Among the speakers was Lindsey Zubritsky, MD, FAAD, or the dermguru, as she’s known on social media. Dr. Zubritsky’s lec
- Advancements in Tendinopathy Treatment: Efficacy of Novel and Traditional Approacheshttps://reachmd.com/news/advancements-in-tendinopathy-treatment-efficacy-of-novel-and-traditional-approaches/2471474/Recent studies highlight the potential of traditional eccentric exercise and innovative Polynucleotides High Purification Technology (PN HPTTM) in treating chronic tendinopathy. These findings may lead healthcare professionals to rethink current practices.